Generation of CRISPR/Cas9 modified human iPSC line with correction of heterozygous mutation in exon 6 of the CaSR gene
Human Cell · 2024
DOI: 10.1007/s13577-024-01135-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von P I Semenova und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Cytology, Russian Academy of Sciences, Saint-Petersburg, 194064, Russia. Hauptthemen laut MEDLINE: Receptors, Calcium-Sensing, Induced Pluripotent Stem Cells, Exons, CRISPR-Cas Systems. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The calcium-sensing receptor (CaSR) gene encodes a cell membrane G protein-coupled receptor (GPCR) which has a key role in maintaining the extracellular Ca2+ homeostasis. We aimed at correcting the compound heterozygous mutation in the 6th [c.1656delA, p.I554SfsX73] and 7th [c.2217 T > A, p.C739X] exons of the CASR gene which the original patient-derived iPSC line had. The mutation is associated with neonatal severe primary hyperparathyroidism of the patient. We generated and characterized a CRISP/Cas9-edited hiPSC line with the restored sequence in the sixth exon of the CASR gene, bearing only heterozygous mutation in the 7th exon. The results showed that the new genetically modified cell line has karyotype without abnormalities, typical hiPSCs morphology, characteristic expression of pluripotency markers, and ability to develop into three germ layers, and differentiates in chondrogenic, adipogenic, osteogenic directions. This new cell line will complement the existing pool of CaSR-mutated cell lines, a valuable resource for in-depth understanding of neonatal severe primary hyperparathyroidism. This will allow further exploration of the application of pharmacological drugs in the context of personalized medicine to correct Ca-homeostasis disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Institute of Cytology, Russian Academy of Sciences, Saint-Petersburg, 194064, Russia.
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russia.
- Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, 117971, Russia.
- St. Petersburg Branch of the Vavilov Institute of General Genetics, Saint-Petersburg, 199034, Russia.
- Research Centre for Medical Genetics, Moscow, 115478, Russia.
- Endocrinology Research Centre, Moscow, 115478, Russia.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Semenova, P. I., Panova, A. V., Sopova, J. V., Krasnova, O. A., Turilova, V. I., Yakovleva, T. K., Kulikova, K. S., Petrova, D. A., Kiselev, S. L., & Neganova, I. E. (2024). Generation of CRISPR/Cas9 modified human iPSC line with correction of heterozygous mutation in exon 6 of the CaSR gene. Human Cell. https://doi.org/10.1007/s13577-024-01135-1
Vancouver
Semenova PI, Panova AV, Sopova JV, Krasnova OA, Turilova VI, Yakovleva TK, et al. Generation of CRISPR/Cas9 modified human iPSC line with correction of heterozygous mutation in exon 6 of the CaSR gene. Human Cell. 2024. doi:10.1007/s13577-024-01135-1
BibTeX
@article{Semenova2024,
author = {Semenova, P I and Panova, A V and Sopova, J V and Krasnova, O A and Turilova, V I and Yakovleva, T K and Kulikova, K S and Petrova, D A and Kiselev, S L and Neganova, I E},
title = {Generation of CRISPR/Cas9 modified human iPSC line with correction of heterozygous mutation in exon 6 of the CaSR gene},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01135-1}
}
EUVIMED